Valeant Teams With Bill Ackman to Buy Allergan

April 23 (Bloomberg) -- Valeant offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Stephanie Ruhle reports on Bill Ackman’s involvement on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)

SolarCity Plunges Amid Shift in Focus
53:29 - SolarCity installed 272 megawatts of panels during the fourth quarter, according to a letter to shareholders posted on its website Tuesday. That fell short of its October forecast of 280 megawatts to 300 megawatts. Bloomberg Intelligence's Kit Konolige has more on "Bloomberg West." (Source: Bloomberg)
  • ESPN's Flagging Profits Overshadow 'Star Wars' at Disney
  • Has Monetary Policy Reached Its Limit in Japan?
  • INCJ Said to Pitch Sharp on Smart-Appliance Plan